Integrating Network Pharmacology and In vivo Experimental Validation to Reveal the Mechanism of FuZheng YiLiu Formula on Estrogen Receptor Positive Breast Cancer
CONCLUSION: In this study, the potential active ingredients, potential core targets, key biological pathways, and signaling pathways involved in the treatment of breast cancer with FZYL were identified, providing a theoretical basis for further anti ER+ breast cancer research.PMID:37957900 | DOI:10.2174/0113862073255044231027061742
Source: Combinatorial Chemistry and High Throughput Screening - Category: Chemistry Authors: Yuan Xu Ying-Xuan Zhang Hong-Yu Chen Li-Sheng Chang Xiao-Jun Gou Wen-Li Chen Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemistry | Databases & Libraries | Drugs & Pharmacology | Genetics | Molecular Biology | Study